Edition:
United Kingdom

Ignyta Inc (RXDX.OQ)

RXDX.OQ on NASDAQ Stock Exchange Capital Market

15.25USD
4:41pm GMT
Change (% chg)

$-0.30 (-1.93%)
Prev Close
$15.55
Open
$15.60
Day's High
$15.80
Day's Low
$15.15
Volume
134,276
Avg. Vol
244,300
52-wk High
$18.25
52-wk Low
$4.65

Latest Key Developments (Source: Significant Developments)

Ignyta Q3 loss per share $0.51
Tuesday, 7 Nov 2017 

Nov 7 (Reuters) - Ignyta Inc ::Ignyta announces third quarter 2017 company highlights and financial results.Q3 loss per share $0.51.Q3 earnings per share view $-0.54 -- Thomson Reuters I/B/E/S.Ignyta Inc - qtrly ‍loss per share $0.51​.Ignyta Inc says ‍ignyta did not record any revenue for Q3 of 2017 or for Q3 of 2016​.  Full Article

Ignyta says public offering of 10.0 million common shares priced at $16.00per share
Friday, 20 Oct 2017 

Oct 19 (Reuters) - Ignyta Inc ::Ignyta announces pricing of public offering of common stock.Says public offering of 10.0 million common shares priced at $16.00per share.  Full Article

Ignyta Inc files for potential mixed shelf offering; size not disclosed
Wednesday, 18 Oct 2017 

Oct 18 (Reuters) - Ignyta Inc :Ignyta Inc files for potential mixed shelf offering; size not disclosed - SEC filing‍​.  Full Article

Ignyta announces proposed public offering of common stock
Wednesday, 18 Oct 2017 

Oct 18 (Reuters) - Ignyta Inc :Ignyta announces proposed public offering of common stock.Ignyta Inc says ‍commenced an underwritten public offering of $125.0 million of shares of its common stock​.Ignyta Inc says ‍anticipates using net proceeds from offering to fund research and development activities for its development programs​.  Full Article

Ignyta Q2 loss per share $0.70
Tuesday, 9 Aug 2016 

Ignyta Inc : Ignyta announces second quarter 2016 company highlights and financial results . Q2 earnings per share view $-0.65 -- Thomson Reuters I/B/E/S . Q2 loss per share $0.70 .Says ignyta did not record any revenue for three months ended june 30, 2016.  Full Article

Cidara therapeutics says Matthew Onaitis appointed CFO
Tuesday, 5 Jul 2016 

Cidara Therapeutics Inc : Says Matthew W. Onaitis appointed CFO .Prior to joining Cidara, Onaitis was general counsel and secretary of Ignyta, Inc.  Full Article

Ignyta Q1 loss per share $0.79
Tuesday, 10 May 2016 

Ignyta Inc : Says did not record any revenue for three months ended march 31, 2016, or for three months ended march 31, 2015 . Ignyta announces first quarter 2016 company highlights and financial results . Q1 loss per share $0.79 .Q1 earnings per share view $-0.68 -- Thomson Reuters I/B/E/S.  Full Article

Ignyta, Inc announces proposed public offering of common stock
Wednesday, 27 Apr 2016 

Ignyta, Inc:Commenced an underwritten public offering to sell approximately $50.0 million of shares of its common stock.Ignyta expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of common stock offered in the public offering at the public offering price, less the underwriting discounts and commissions.Net proceeds from the offering to fund research and development activities for its development programs.J.P. Morgan Securities LLC is acting as lead book-running manager for the offering. Piper Jaffray & Co. is also acting as a book-running manager.  Full Article

BRIEF-Ignyta announces new data highlighting immune modulation of RXDX-106 at the society for immunotherapy of cancer meeting

* Ignyta announces new data highlighting immune modulation of RXDX-106 at the society for immunotherapy of cancer (sitc) meeting Source text for Eikon: Further company coverage: